NYSE · AVTR
Healthcare · Medical - Instruments & Supplies
$14.20
Down-$0.34 (-2.34%)
Updated Sep 2, 2026, 1:03 PM
SID Score
6.2/10
Composite research score
Smart Money
58/100
Neutral
Price performance
1M range · 21 trading sessions · Daily adjusted prices
AVTR closed at $14.20 after 21 trading sessions, up 3.80% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 1, 2026 | $14.55 | $14.63 | $14.19 | $14.20 | 5.68M |
| Aug 31, 2026 | $14.54 | $14.59 | $14.34 | $14.54 | 6.54M |
| Aug 28, 2026 | $14.50 | $14.65 | $14.45 | $14.58 | 5.3M |
| Aug 27, 2026 | $14.51 | $14.70 | $14.43 | $14.61 | 6M |
| Aug 26, 2026 | $14.23 | $14.625 | $14.20 | $14.50 | 4.77M |
| Aug 25, 2026 | $14.26 | $14.50 | $14.05 | $14.42 | 5.56M |
| Aug 24, 2026 | $14.29 | $14.36 | $14.05 | $14.26 | 5.19M |
| Aug 21, 2026 | $14.31 | $14.485 | $14.16 | $14.46 | 6.06M |
| Aug 20, 2026 | $13.79 | $14.48 | $13.755 | $14.25 | 7.13M |
| Aug 19, 2026 | $13.56 | $14.11 | $13.505 | $13.96 | 6.42M |
| Aug 18, 2026 | $13.61 | $13.724 | $13.325 | $13.33 | 6.31M |
| Aug 17, 2026 | $13.54 | $13.72 | $13.45 | $13.50 | 4.54M |
| Aug 14, 2026 | $13.78 | $13.825 | $13.63 | $13.66 | 3.96M |
| Aug 13, 2026 | $13.98 | $14.02 | $13.66 | $13.85 | 5.94M |
| Aug 12, 2026 | $13.57 | $13.94 | $13.42 | $13.93 | 6.2M |
| Aug 11, 2026 | $13.65 | $13.81 | $13.54 | $13.77 | 7.64M |
| Aug 10, 2026 | $13.50 | $13.79 | $13.40 | $13.73 | 6.43M |
| Aug 7, 2026 | $13.33 | $13.59 | $13.235 | $13.59 | 6.22M |
| Aug 6, 2026 | $13.40 | $13.50 | $13.08 | $13.18 | 8.74M |
| Aug 5, 2026 | $13.80 | $13.82 | $13.265 | $13.36 | 9.57M |
| Aug 4, 2026 | $13.71 | $13.76 | $13.23 | $13.68 | 11.82M |
The latest Smart Investors Daily articles mentioning AVTR.
AVTR research
Company profile and research snapshot.
Avantor Inc provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company has three geographic segments: the Americas, Europe, and AMEA. The company's product group consists of Equipment & instrumentation, Services & specialty procurement, Proprietary materials & consumables, and Third-party materials & consumables. Materials & consumables include high-purity chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, and education and microbiology and clinical trial kits, peristaltic pumps and fluid handling tips.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jul 30, 2026 | Evercore ISI Group | In-Line | — |
| Jul 30, 2026 | Wells Fargo | Overweight | — |
| Jul 30, 2026 | Stifel | Hold | — |
| Jul 30, 2026 | RBC Capital | Sector Perform | — |
| Jul 30, 2026 | Morgan Stanley | Equal-Weight | — |
No generated briefing is available yet.
SeekingAlpha · Aug 28, 2026
Avantor outlook update: organic growth returns, leverage eases, and guidance rises. Click to read my analysis for more about the risks and potential rewards.
Yahoo · Aug 19, 2026
SOUTH JORDAN, Utah, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer of healthcare technology, today announced that Sheri Lewis has agreed to join Merit as Executive Vice President of Global Operations, effective August 31, 2026. Ms. Lewis brings three decades of experience across global operations, manufacturing, and supply chain management. She previously held senior roles at SkinHealth Systems, Inc., Avantor, Medtronic, and Honeywell,
Yahoo · Aug 19, 2026
Here is how Avantor, Inc. (AVTR) and BrightSpring Health Services, Inc. (BTSG) have performed compared to their sector so far this year.
Yahoo · Aug 11, 2026
HIMS posts a wider-than-expected loss and weaker gross margin in second-quarter 2026 despite strong revenue growth and a raised full-year outlook.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning AVTR.
